Comerica Bank’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $18.4M | Buy |
153,719
+41,112
| +37% | +$4.92M | 0.14% | 131 |
|
|
2022
Q3 | $12M | Buy |
112,607
+3,520
| +3% | +$376K | 0.1% | 193 |
|
|
2022
Q2 | $9.59M | Buy |
109,087
+19,610
| +22% | +$1.72M | 0.08% | 260 |
|
|
2022
Q1 | $9.81M | Buy |
89,477
+2,027
| +2% | +$222K | 0.07% | 287 |
|
|
2021
Q4 | $9.93M | Buy |
87,450
+19,411
| +29% | +$2.2M | 0.07% | 272 |
|
|
2021
Q3 | $9.84M | Sell |
68,039
-4,232
| -6% | -$612K | 0.06% | 355 |
|
|
2021
Q2 | $8.61M | Buy |
72,271
+28,180
| +64% | +$3.36M | 0.05% | 414 |
|
|
2021
Q1 | $5.82M | Buy |
44,091
+15,143
| +52% | +$2M | 0.03% | 648 |
|
|
2020
Q4 | $4.65M | Buy |
28,948
+12,125
| +72% | +$1.95M | 0.03% | 744 |
|
|
2020
Q3 | $2.69M | Buy |
16,823
+1,617
| +11% | +$258K | 0.02% | 924 |
|
|
2020
Q2 | $2.17M | Buy |
15,206
+1,123
| +8% | +$160K | 0.02% | 1033 |
|
|
2020
Q1 | $1.82M | Buy |
14,083
+11,671
| +484% | +$1.51M | 0.02% | 970 |
|
|
2019
Q4 | $323K | Buy |
2,412
+45
| +2% | +$6.03K | ﹤0.01% | 2037 |
|
|
2019
Q3 | $249K | Sell |
2,367
-93
| -4% | -$9.78K | ﹤0.01% | 2116 |
|
|
2019
Q2 | $277K | Buy |
2,460
+179
| +8% | +$20.2K | ﹤0.01% | 2095 |
|
|
2019
Q1 | $275K | Buy |
+2,281
| New | +$275K | ﹤0.01% | 2094 |
|